Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-07-05

Clinical Trial Update: A Food Effect Study to Assess Pharmacokinetics of Hemay005 in Healthy Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 study assesses the effect of food on the pharmacokinetics of Hemay005 in healthy volunteers as part of psoriasis drug development.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hemay005

Snippet

Sponsor: Tianjin Hemay Bio-Tech Co., Ltd | Conditions: Psoriasis | Phase 1 | Status: UNKNOWN